B2LA1 Polyclonal Antibody

This gene encodes a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators that are involved in a wide variety of cellular activities such as embryonic development, homeostasis and tumorigenesis. The protein encoded by this gene is able to reduce the release of pro-apoptotic cytochrome c from mitochondria and block caspase activation. This gene is a direct transcription target of NF-kappa B in response to inflammatory mediators, and is up-regulated by different extracellular signals, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), CD40, phorbol ester and inflammatory cytokine TNF and IL-1, which suggests a cytoprotective function that is essential for lymphocyte activation as well as cell survival. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Introducing the B2LA1 Polyclonal Antibody, a cutting-edge scientific tool designed to revolutionize the field of immunology. This meticulously crafted antibody is the result of extensive research and development, ensuring unparalleled specificity and sensitivity in detecting target antigens.

The B2LA1 Polyclonal Antibody boasts a superior affinity for its target, enabling precise and accurate identification of even the most elusive antigens. Its exceptional binding capacity guarantees reliable and reproducible results, making it an indispensable asset for researchers and clinicians alike.

Crafted with utmost precision, the B2LA1 Polyclonal Antibody exhibits exceptional stability and durability, ensuring consistent performance across a wide range of experimental conditions. Its robust nature allows for prolonged usage without compromising its efficacy, providing researchers with a cost-effective solution for their immunological studies.

Furthermore, the B2LA1 Polyclonal Antibody is meticulously purified to eliminate any potential cross-reactivity, ensuring unparalleled specificity in target recognition. This feature not only enhances the accuracy of experimental results but also minimizes the risk of false positives, thereby streamlining the research process.

The B2LA1 Polyclonal Antibody is supplied in a convenient and user-friendly format, facilitating seamless integration into various laboratory protocols. Its compatibility with multiple applications, including Western blotting, immunohistochemistry, and flow cytometry, makes it a versatile tool for a wide array of research endeavors.

In summary, the B2LA1 Polyclonal Antibody represents a breakthrough in immunological research, offering researchers and clinicians an invaluable tool for precise and reliable antigen detection. With its exceptional specificity, stability, and compatibility, this antibody is poised to redefine the boundaries of scientific exploration in the field of immunology.